Mumbai, February 25 (Udaipur Kiran): Biocon is currently trading at Rs. 391.40, up by 1.05 points or 0.27% from its previous closing of Rs. 390.35 on the BSE.
The scrip opened at Rs. 392.90 and has touched a high and low of Rs. 395.00 and Rs. 390.30 respectively. So far 28172 shares were traded on the counter.
The BSE group ‘A’ stock of face value Rs. 5 has touched a 52 week high of Rs. 424.95 on 18-Nov-2025 and a 52 week low of Rs. 290.80 on 03-Mar-2025.
Last one week high and low of the scrip stood at Rs. 395.00 and Rs. 377.55 respectively. The current market cap of the company is Rs. 63336.97 crore.
The promoters holding in the company stood at 54.45%, while Institutions and Non-Institutions held 29.10% and 16.45% respectively.
Biocon has received approval from the United States Food and Drug Administration (USFDA) for its complex formulation Liraglutide Injection, 18 mg/3 mL (6 mg/mL) single-patient-use prefilled pens (gSaxenda). Liraglutide is a drug-device combination formulation used in the treatment of chronic weight management, indicated as an adjunct to a reduced-calorie diet and increased physical activity.
Liraglutide is a synthetic analog of Glucagon-like peptide-1 (GLP-1) and is administered as a once-daily injection. GLP-1 receptor agonists have emerged as one of the fastest growing therapeutic classes globally, driven by the rising prevalence of obesity and metabolic disorders, strong clinical outcomes, and increasing physician adoption. According to IQVIA MAT December 2025 the total addressable market opportunity for GLP-1 in weight loss in the U.S. was $127 million.
Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient’s worldwide.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.
